These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 24341415)

  • 41. Turn-on phosphorescent chemodosimeter for Hg2+ based on a cyclometalated Ir(III) complex and its application in time-resolved luminescence assays and live cell imaging.
    Ru JX; Guan LP; Tang XL; Dou W; Yao X; Chen WM; Liu YM; Zhang GL; Liu WS; Meng Y; Wang CM
    Inorg Chem; 2014 Nov; 53(21):11498-506. PubMed ID: 25333867
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of two mitochondrial-targeting cyclometalated iridium(III) complexes as potent anti-glioma stem cells agents.
    Peng W; Hegazy AM; Jiang N; Chen X; Qi HX; Zhao XD; Pu J; Ye RR; Li RT
    J Inorg Biochem; 2020 Feb; 203():110909. PubMed ID: 31689591
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alkyl chain-modified cyclometalated iridium complexes as tunable anticancer and imaging agents.
    Laha P; De U; Chandra F; Dehury N; Khullar S; Kim HS; Patra S
    Dalton Trans; 2018 Nov; 47(44):15873-15881. PubMed ID: 30358775
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [New highly phosphorescent heteroleptic tris-cyclometalated iridium (III) complexes: synthesis and photophysical characterization].
    Guo XX; Hao YY; Lei JF; Fan WH; Wang H; Xu BS
    Guang Pu Xue Yu Guang Pu Fen Xi; 2010 Jan; 30(1):170-3. PubMed ID: 20302107
    [TBL] [Abstract][Full Text] [Related]  

  • 45. AcetylacetonateBODIPY-Biscyclometalated Iridium(III) Complexes: Effective Strategy towards Smarter Fluorescent Photosensitizer Agents.
    Palao E; Sola-Llano R; Tabero A; Manzano H; Agarrabeitia AR; Villanueva A; López-Arbeloa I; Martínez-Martínez V; Ortiz MJ
    Chemistry; 2017 Jul; 23(42):10139-10147. PubMed ID: 28543812
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cyclometalated Ir(III) complexes as targeted theranostic anticancer therapeutics: combining HDAC inhibition with photodynamic therapy.
    Ye RR; Tan CP; He L; Chen MH; Ji LN; Mao ZW
    Chem Commun (Camb); 2014 Sep; 50(75):10945-8. PubMed ID: 25096019
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cationic Amphiphilic Tris-Cyclometalated Iridium(III) Complexes Induce Cancer Cell Death via Interaction with Ca
    Hisamatsu Y; Suzuki N; Masum AA; Shibuya A; Abe R; Sato A; Tanuma SI; Aoki S
    Bioconjug Chem; 2017 Feb; 28(2):507-523. PubMed ID: 28032992
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis, characterization and anticancer activity in vitro and in vivo evaluation of an iridium (III) polypyridyl complex.
    Yi QY; Wan D; Tang B; Wang YJ; Zhang WY; Du F; He M; Liu YJ
    Eur J Med Chem; 2018 Feb; 145():338-349. PubMed ID: 29331805
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A new class of iridium complexes suitable for stepwise incorporation into linear assemblies: synthesis, electrochemistry, and luminescence.
    Whittle VL; Williams JA
    Inorg Chem; 2008 Aug; 47(15):6596-607. PubMed ID: 18186628
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rational design, synthesis, and characterization of deep blue phosphorescent Ir(III) complexes containing (4'-substituted-2'-pyridyl)-1,2,4-triazole ancillary ligands.
    Park HJ; Kim JN; Yoo HJ; Wee KR; Kang SO; Cho DW; Yoon UC
    J Org Chem; 2013 Aug; 78(16):8054-64. PubMed ID: 23865939
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An investigation on the second order nonlinear optical response of tris-cyclometallated Ir(III) complexes with variously substituted 2-phenylpyridines.
    Zaarour M; Guerchais V; Le Bozec H; Dragonetti C; Righetto S; Roberto D; De Angelis F; Fantacci S; Lobello MG
    Dalton Trans; 2013 Jan; 42(1):155-9. PubMed ID: 23051730
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hetero-Bis-Conjugation of Bioactive Molecules to Half-Sandwich Ruthenium(II) and Iridium(III) Complexes Provides Synergic Effects in Cancer Cell Cytotoxicity.
    Biancalana L; Kostrhunova H; Batchelor LK; Hadiji M; Degano I; Pampaloni G; Zacchini S; Dyson PJ; Brabec V; Marchetti F
    Inorg Chem; 2021 Jul; 60(13):9529-9541. PubMed ID: 34156246
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nitroimidazole and glucosamine conjugated heteroscorpionate ligands and related copper(II) complexes. Syntheses, biological activity and XAS studies.
    Pellei M; Papini G; Trasatti A; Giorgetti M; Tonelli D; Minicucci M; Marzano C; Gandin V; Aquilanti G; Dolmella A; Santini C
    Dalton Trans; 2011 Oct; 40(38):9877-88. PubMed ID: 21709917
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties.
    Li Y; Liu B; Xu CX; He L; Wan YC; Ji LN; Mao ZW
    J Biol Inorg Chem; 2020 Jun; 25(4):597-607. PubMed ID: 32232583
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis, molecular structure, computational study and in vitro anticancer activity of dinuclear thiolato-bridged pentamethylcyclopentadienyl Rh(III) and Ir(III) complexes.
    Gupta G; Garci A; Murray BS; Dyson PJ; Fabre G; Trouillas P; Giannini F; Furrer J; Süss-Fink G; Therrien B
    Dalton Trans; 2013 Nov; 42(43):15457-63. PubMed ID: 24022745
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An iridium (III) complex as potent anticancer agent induces apoptosis and autophagy in B16 cells through inhibition of the AKT/mTOR pathway.
    Tang B; Wan D; Wang YJ; Yi QY; Guo BH; Liu YJ
    Eur J Med Chem; 2018 Feb; 145():302-314. PubMed ID: 29331753
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acid-induced degradation of phosphorescent dopants for OLEDs and its application to the synthesis of tris-heteroleptic iridium(III) bis-cyclometalated complexes.
    Baranoff E; Curchod BF; Frey J; Scopelliti R; Kessler F; Tavernelli I; Rothlisberger U; Grätzel M; Nazeeruddin MK
    Inorg Chem; 2012 Jan; 51(1):215-24. PubMed ID: 22148629
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Liposomes encapsulated iridium(III) polypyridyl complexes enhance anticancer activity in vitro and in vivo.
    Bai L; Fei WD; Gu YY; He M; Du F; Zhang WY; Yang LL; Liu YJ
    J Inorg Biochem; 2020 Apr; 205():111014. PubMed ID: 32044395
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Water reduction systems associated with homoleptic cyclometalated iridium complexes of various 2-phenylpyridines.
    Yuan YJ; Yu ZT; Cai JG; Zheng C; Huang W; Zou ZG
    ChemSusChem; 2013 Aug; 6(8):1357-65. PubMed ID: 23843363
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Iridium(iii) complexes with five-membered heterocyclic ligands for combined photodynamic therapy and photoactivated chemotherapy.
    Wu N; Cao JJ; Wu XW; Tan CP; Ji LN; Mao ZW
    Dalton Trans; 2017 Oct; 46(39):13482-13491. PubMed ID: 28951916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.